ReoPro (abciximab) to inhibit blood clotting

You'll see more physicians using ReoPro (abciximab) to inhibit blood clotting.

This biotech anti-platelet drug came out earlier this year. It's for patients undergoing balloon help keep the coronary artery open.

So far it's only approved for high-risk patients. But now there's evidence of an overwhelming benefit in reducing heart attack and death...even after routine cases of angioplasty.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote